13 January 2012 - US-based vaccine developer Nuron Biotech Inc said on Friday that it had signed a licensing agreement with Mitsubishi Tanabe Pharma Corporation (TYO:4508), or MTPC, for the sales of its HibTITER vaccine in the Japanese market for both the single entity and for combination product us...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up